Radiant Innovation

Radiant Innovation FCF Growth

The Year-over-Year Free Cash Flow Growth of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -175.02 %. In the previous year, Year-over-Year Free Cash Flow Growth was 243.31 % — a change of -171.93% (lower).

FCF Growth

-175.02 %

YoY

-171.93%

Last updated:

Year-over-Year Free Cash Flow Growth of Radiant Innovation is 2025 -175.02 % . Year-over-Year Free Cash Flow Growth of Radiant Innovation was 2024 243.31 % . It decreases by -171.93% lower compared to the previous year.

The Radiant Innovation FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
109.84 TWD
Jan 1, 2019
1,577.79 TWD
Jan 1, 2020
1,079.47 TWD
Jan 1, 2021
-120.36 TWD
Jan 1, 2022
70.97 TWD
Jan 1, 2023
88.96 TWD
Jan 1, 2024
243.31 TWD
Jan 1, 2025
-175.02 TWD
The Radiant Innovation FCF Growth history
YEARFCF GrowthYoY
-175.02 %-171.93%
243.31 %+173.49%
88.96 %+25.35%
70.97 %-158.97%
-120.36 %-111.15%
1,079.47 %-31.58%
1,577.79 %+1,336.43%
109.84 %-167.36%
-163.07 %-182.04%
198.77 %-263.16%
-121.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Year-over-Year Free Cash Flow Growth of Radiant Innovation is -175.02 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Radiant Innovation

All Key Metrics — Radiant Innovation